Liquid CoQ10 Feed Composition for Stable Pet Supplement Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for a supplementary feed that can prevent aging, cardiovascular disease, and heart disease in companion animals while providing high absorption and bioavailability, using coenzyme Q10, conjugated linoleic acid, fructooligosaccharide, L-carnitine, and taurine in specific amounts.
Innovation Solution
A liquid supplementary feed composition comprising 0.5 to 40% coenzyme Q10, 0.01 to 35% conjugated linoleic acid, 1 to 45% fructooligosaccharide, 0.001 to 15% L-carnitine, and 0.01 to 20% taurine, with optional additives like glycerin, emulsifiers, and flavorings, to enhance stability and absorption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If coenzyme Q10 is used to prevent aging and cardiovascular disease, then health benefits are improved, but stability deteriorates due to sensitivity to light, heat and oxygen
Solution Approach 1:
The patent introduces an intermediary substance (emulsifier or carrier) to protect coenzyme Q10 from direct exposure to de stabilizing factors. The coenzyme Q10 is incorporated into an emulsion or carrier system that acts as a barrier against light, heat and oxygen, thereby maintaining stability while preserving health benefits.
Solution Approach 2:
The patent changes the physical state and environmental parameters of coenzyme Q10 by formulating it in a liquid emulsion system with controlled pH, temperature and oxidation conditions. This parameter control prevents degradation while maintaining the antioxidant and health-promoting properties.
2Reliability
If coenzyme Q10 is used to prevent aging, then anti-aging effects are improved, but bioavailability deteriorates due to insolubility in water and organic solvents
Solution Approach 1:
The patent uses an emulsifier or carrier substance as an intermediary to bridge the insolubility problem. The emulsifier facilitates the dissolution and absorption of coenzyme Q10 in biological systems, improving bioavailability while maintaining anti-aging effects.
Solution Approach 2:
The patent changes the solubility parameters of coenzyme Q10 by formulating it in a liquid emulsion system with specific surface active agents and carriers. This formulation approach enables better dissolution and absorption in aqueous environments, thereby improving bioavailability.
3Reliability
If coenzyme Q10 content is increased to enhance antioxidant effect, then health benefits are improved, but stability deteriorates due to increased sensitivity to environmental factors
Solution Approach 1:
The patent introduces protective intermediaries (emulsifiers, antioxidants, carriers) that shield high concentrations of coenzyme Q10 from environmental degradation. These intermediaries prevent oxidation and degradation while allowing the formulation to maintain high antioxidant activity.
Solution Approach 2:
The patent creates a composite formulation system combining coenzyme Q10 with stabilizing agents, emulsifiers and carriers. This composite approach allows high coenzyme Q10 content to be maintained while preserving stability through the protective effects of the composite components.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively prevents aging and cardiovascular diseases, activates the immune system, and provides dietary benefits with improved bioavailability and stability, maintaining active ingredients over time.
Implementation Method 1
Coenzyme Q10 is an antioxidant called CoQ10, Ubiquinone or Ubidecarenone... It is not only present in all cells, but also produced in the body, and is an important substance responsible for 95% of the cell and energy generation pathways.
Implementation Method 2
CLA is gaining a lot of attention as a slimming ingredient because it is known to have a dietary effect on body fat, especially abdominal fat, by directly acting on fat cells in the body, preventing them from absorbing fat, increasing the breakdown and metabolic rate of fat cells
Implementation Method 3
fructooligosaccharide... 1 to 45% by weight of fructooligosaccharide
Implementation Method 4
L-carnitine... 0.001 to 15% by weight of L-carnitine
Implementation Method 5
taurine... 0.01 to 20% by weight of taurine
Data Source
AI summary
The present invention relates to a liquid-phase, supplementary feed composition containing coenzyme Q10 and, more specifically, to a liquid-phase, supplementary feed composition containing coenzyme Q10, conjugated linoleic acid, fructooligosaccharide, L-carnitine, and taurine at specific contents, whereby the composition can prevent aging and onset of cardiovascular diseases and cardiac disease, activate the immune system, and provide a diet effect in companion animals.